Next Article in Journal
Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
Next Article in Special Issue
Evaluation of the Real-World Effectiveness of Vaccines against COVID-19 at a Local Level: Protocol for a Test-Negative Case–Control Study
Previous Article in Journal
Optimization, Production, Purification and Characterization of HIV-1 GAG-Based Virus-like Particles Functionalized with SARS-CoV-2
Previous Article in Special Issue
Reduced Humoral Response of SARS-CoV-2 Antibodies following Vaccination in Patients with Inflammatory Rheumatic Diseases—An Interim Report from a Danish Prospective Cohort Study
 
 
Communication

Article Versions Notes

Vaccines 2022, 10(2), 253; https://doi.org/10.3390/vaccines10020253
Action Date Notes Link
article pdf uploaded. 7 February 2022 16:56 CET Version of Record https://www.mdpi.com/2076-393X/10/2/253/pdf-vor
article xml file uploaded 10 February 2022 06:12 CET Original file -
article xml uploaded. 10 February 2022 06:12 CET Update https://www.mdpi.com/2076-393X/10/2/253/xml
article pdf uploaded. 10 February 2022 06:12 CET Updated version of record https://www.mdpi.com/2076-393X/10/2/253/pdf
article html file updated 10 February 2022 06:14 CET Original file -
article html file updated 31 July 2022 12:00 CEST Update https://www.mdpi.com/2076-393X/10/2/253/html
Back to TopTop